Media ReleasesBARD1 Life Sciences

View All BARD1 Life Sciences News


BARD1 Life Sciences - EXO-NET Presented at Virtual ANZSEV Symposium


BARD1 Life Sciences Limited (ASX:BD1) (BARD1 or the Company) is pleased to announce that Dr Emily Stein, BARD1 Technology Director and founding scientist of the Molecular Nets technology, will be presenting about its EXO-NET® exosome capture tool at the virtual Australian & New Zealand Society for Extracellular Vesicles (ANZSEV) Symposium today.

For more information, download the attached PDF.

Download this document

Are you a 708 sophisticated investor?

A sophisticated investor is defined under Section 708 of the Corporations Act (net assets of $2.5 million or annual incomes in excess of $250,000).

They are eligible to receive information regarding wholesale investment opportunities that are not available to regular or retail investors.

Please subscribe if you would like to be alerted to these types of opportunities.